159 related articles for article (PubMed ID: 37928644)
1. Two-carbon tethered artemisinin-isatin hybrids: design, synthesis, anti-breast cancer potential, and
Wang R; Huang R; Yuan Y; Wang Z; Shen K
Front Mol Biosci; 2023; 10():1293763. PubMed ID: 37928644
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and anti-breast cancer properties of butyric ester tethered dihydroartemisinin-isatin hybrids.
Zhao S; Zhang X; Tang M; Liu X; Deng J; Zhou W; Xu Z
Med Chem Res; 2023; 32(4):705-712. PubMed ID: 36816432
[TBL] [Abstract][Full Text] [Related]
3. Novel ester tethered dihydroartemisinin-3-(oxime/thiosemicarbazide)isatin hybrids as potential anti-breast cancer agents: Synthesis, in vitro cytotoxicity and structure-activity relationship.
Liu S; Wang S; Xu D; Pan B; Chen L; Zhao S; Xu Z; Zhou W
Drug Dev Res; 2023 Sep; 84(6):1175-1182. PubMed ID: 37165798
[TBL] [Abstract][Full Text] [Related]
4. The Anti-Breast Cancer Activity of Dihydroartemisinin-5-methylisatin Hybrids Tethered via Different Carbon Spacers.
Yao Y; Wang H; Xu J; Gao F; Cao W
Molecules; 2022 Nov; 27(22):. PubMed ID: 36432095
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Biological Evaluation of Novel Amyl Ester Tethered Dihydroartemisinin-Isatin Hybrids as Potent Anti-Breast Cancer Agents.
Xu Z; Zhang X; Liu J; Zhao S; Liu J; Zhou W
Chem Biodivers; 2023 Mar; 20(3):e202201257. PubMed ID: 36808231
[TBL] [Abstract][Full Text] [Related]
6. Artemisinin-isatin hybrids tethered via ethylene linker and their anti-lung cancer activity.
Wang R; Zhang Q; Chen M
Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200563. PubMed ID: 36572639
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and in vitro cytotoxicity evaluation of novel dihydroartemisinin-isatin hybrids tethered via different length of esters as potential anti-breast cancer agents.
Xu Z; Pan B; Chen L; Xu D
Fitoterapia; 2023 Apr; 166():105436. PubMed ID: 36693438
[TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of novel artemisinin-isatin hybrids with potential anti-leukemic cytotoxicity.
Wang P; Zhang Z; Cao W; Zhang X
Front Oncol; 2023; 13():1112369. PubMed ID: 37124527
[TBL] [Abstract][Full Text] [Related]
9. The Anti-Breast Cancer Potential of Bis-Isatin Scaffolds.
Guo H; Diao QP
Curr Top Med Chem; 2020; 20(16):1499-1503. PubMed ID: 32156238
[TBL] [Abstract][Full Text] [Related]
10. The anti-breast cancer potential of dihydroartemisinin-isatin hybrids with hydrogen bond donors at C-3 position of isatin moiety.
Ding F; Chen X; Cao W; Dong T; Wang P
Fitoterapia; 2023 Mar; 165():105426. PubMed ID: 36608710
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis and Anti-Lung Cancer Evaluation of 1, 2, 3-Triazole Tethered Dihydroartemisinin-Isatin Hybrids.
Hou H; Qu B; Su C; Hou G; Gao F
Front Pharmacol; 2021; 12():801580. PubMed ID: 34975498
[TBL] [Abstract][Full Text] [Related]
12. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
Yang M; Liu H; Zhang Y; Wang X; Xu Z
Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
[TBL] [Abstract][Full Text] [Related]
13. Three-Carbon Linked Dihydroartemisinin-Isatin Hybrids: Design, Synthesis and Their Antiproliferative Anticancer Activity.
Dong M; Zheng G; Gao F; Li M; Zhong C
Front Pharmacol; 2022; 13():834317. PubMed ID: 35153798
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of 1H-1,2,3-Triazole-Linked Quinoline-Isatin Molecular Hybrids as Anti-Breast Cancer and Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents.
Awolade P; Cele N; Ebenezer O; Kerru N; Gummidi L; Gu L; Palma G; Kaur M; Singh P
Anticancer Agents Med Chem; 2021; 21(10):1228-1239. PubMed ID: 32990543
[TBL] [Abstract][Full Text] [Related]
15. Novel Thiazolidinone/Thiazolo[3,2-
El-Naggar M; Eldehna WM; Almahli H; Elgez A; Fares M; Elaasser MM; Abdel-Aziz HA
Molecules; 2018 Jun; 23(6):. PubMed ID: 29895744
[TBL] [Abstract][Full Text] [Related]
16. Development of isatin-thiazolo[3,2-a]benzimidazole hybrids as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: Synthesis, biological and molecular dynamics investigations.
Eldehna WM; El Hassab MA; Abo-Ashour MF; Al-Warhi T; Elaasser MM; Safwat NA; Suliman H; Ahmed MF; Al-Rashood ST; Abdel-Aziz HA; El-Haggar R
Bioorg Chem; 2021 May; 110():104748. PubMed ID: 33684714
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of novel morpholinated isatin-quinoline hybrids as potent anti-breast cancer agents.
Singh A; Kaur H; Arora S; Bedi PMS
Arch Pharm (Weinheim); 2022 Feb; 355(2):e2100368. PubMed ID: 34783073
[TBL] [Abstract][Full Text] [Related]
18. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies.
Singh H; Singh JV; Gupta MK; Saxena AK; Sharma S; Nepali K; Bedi PMS
Bioorg Med Chem Lett; 2017 Sep; 27(17):3974-3979. PubMed ID: 28797799
[TBL] [Abstract][Full Text] [Related]
19. 1
Kumar S; Saha ST; Gu L; Palma G; Perumal S; Singh-Pillay A; Singh P; Anand A; Kaur M; Kumar V
ACS Omega; 2018 Sep; 3(9):12106-12113. PubMed ID: 30320289
[TBL] [Abstract][Full Text] [Related]
20. The In Vitro Anticancer Activity and Potential Mechanism of Action of 1-[(1R,2S)-2-fluorocyclopropyl]Ciprofloxacin-(4-methyl/phenyl/benzyl-3- aryl)-1,2,4-triazole-5(4H)-thione Hybrids.
Zhang YZ; Liu HL; He QS; Xu Z
Curr Top Med Chem; 2020; 20(16):1493-1498. PubMed ID: 32156237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]